Akero Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
01 May 2024	Form 3: Gangloff Scott A., Chief Technology Officer No securities owned
11 Jan 2023	Form 3: Lamy Patrick, See Remarks No securities owned
14 Jul 2021	Form 3: Judy Chou, Director No securities owned
30 Jun 2021	Form 3: Skorpios Trust, 10% owner and 3 others Holds 4,907,829 shares of Common Stock
26 Apr 2021	Form 3: Xu Yuan, Director No securities owned
11 Jun 2020	Form 3: Heyman Tomas J., Director No securities owned
19 Jun 2019	Form 3: Redmile Group, Llc, 10% owner and 1 other
19 Jun 2019	Form 3: venBio Global Strategic Fund Ii L.p., 10% owner and 4 others
19 Jun 2019	Form 3: Atlas Venture Fund XI, L.p., 10% owner and 5 others
19 Jun 2019	Form 3: White William Richard, EVP, Chief Financial Officer
19 Jun 2019	Form 3: Young Jonathan, EVP, Chief Operating Officer Holds 192,909 shares of Common Stock
19 Jun 2019	Form 3: Bitterman Kevin, Director
19 Jun 2019	Form 3: Versant Venture Capital VI, L.p., 10% owner
19 Jun 2019	Form 3: Rolph Timothy, Chief Scientific Officer Holds 192,909 shares of Common Stock
19 Jun 2019	Form 3: Harrison Seth Loring, Director
19 Jun 2019	Form 3: Iwicki Mark T, Director
19 Jun 2019	Form 3: Henderson Jane, Director
19 Jun 2019	Form 3: Yale Catriona, Chief Development Officer Holds 162,644 shares of Common Stock
19 Jun 2019	Form 3: Graham G. Walmsley, Director No securities owned
19 Jun 2019	Form 3: Apple Tree Partners IV, L.p., 10% owner and 2 others

Comments